Results within minutes
With speed in mind, we designed the heart of the rapifleX® MALDI Imaging solution to work up to 20 times faster than traditional MALDI-TOF systems, to meet the increasing requirements of tissue imaging or high-throughput primary screening.
The adaptable ion optics and class leading laser technology provide the best data quality, regardless of the acquisition mode or mass range.
The unprecedented 10 kHz speed and ion source robustness, the wide dynamic range, higher specificity and resolution, all contribute to the detailed
characterization of biologically and clinically relevant lipids, peptides and proteins, raising customer MALDI-TOF/TOF expectations for applications such as:
The rapifleX® combines state-of-the-art technology with advanced informatics into a system that gives you speed, robustness, versatility and confidence. The platform offers a complete characterization system with unprecedented speed of analysis and performance.
Speed - highest throughput provides 5-20 times increase in speed
Robustness - User removable ion source for easy cleaning, designed for maximum uptime in 24/7 operations
MALDI provides single charged ions and fragment ions of molecules that are difficult to analyze using ESI. Non-tryptic peptides can be well analyzed by MALDI MS/MS. Spectra that are otherwise difficult to analyze and inspect can be easily interpreted, such as MS/MS spectra of glycopeptides or disulfide/trisulfide linked peptides. Top-Down spectra of proteins as large as intact antibodies can be automatically interpreted.
Glycopeptide analysis is an important step in quality control of recombinant antibodies. The high precursor selection resolution and isotopically resolved fragments over the mass range enables the characterization of non-tryptic or hydrophobic peptide. The speed of MALDI analysis allows for faster batch releases for your production workflows.
Top-down sequencing at a new level: optimized MALDI laser for high performance top-down protein sequencing and the high resolution provide for unmatched sequence analysis of intact proteins. Terminal modification status and sequence assessment, full protein sequence confirmation and sequence error curation are usual applications.
Top-down sequencing of proteins with outstanding sequence coverage allowing the unambiguous identification of modifications, like disulfide/trisulfide analysis via LC-MALDI, and mutation sites.
The new rapifleX® MALDI PharmaPulse® is the first solution to offer the speed, specificity and robustness required for large primary screens in drug discovery:
The rapifleX® MALDI Tissuetyper® is the complete solution for MALDI Imaging.
"In our lab, with its high MS2 isolation efficiency, resolution and mass accuracy at high m/z values, the rapifleX® TOF/TOF has been instrumental in identifying and characterizing new subunits of membrane protein complexes, including prokaryotic respiratory chain complexes and antibiotic drug targets."
For Research Use Only. Not for use in clinical diagnostic procedures.